Stay updated on Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial

Sign up to get notified when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the previous revision v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-11T14:11:42.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, and the older funding-related notice (v3.4.1) has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:16:27.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a government funding notice banner at the top of the page and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:28:14.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a glossary toggle, normalized capitalization for QC-related labels and No FEAR Act text, and updated the page revision to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T00:31:18.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no user-visible changes to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:54:15.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page now lists updated study locations, adding Connecticut, Louisiana, Minnesota, Missouri, South Carolina, Tennessee, British Columbia, and Manitoba, and includes a revision note (v3.3.3). The previous location sections have been removed, reflecting an update to the location information presented on the page.
    Difference
    0.9%
    Check dated 2025-12-23T09:22:37.000Z thumbnail image

Stay in the know with updates to Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.